Garland Surgical Overview
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A2
- (Upcoming)
- Latest Deal Amount
-
$6M
- Investors
-
11
Garland Surgical General Information
Description
Developer of orthopedic implant technology designed for total hip replacement procedures. The company develops ultra-low-wear hip implants intended for long-term use across diverse patient populations, enabling healthcare providers to offer durable joint replacement solutions suitable for patients regardless of age or gender.
Contact Information
Website
www.garlandsurgical.healthCorporate Office
- Lower Gurnox Farm Easinghope Lane
- Broadwas On Teme
- Worcester WR6 5PA
- England, United Kingdom
Corporate Office
- Lower Gurnox Farm Easinghope Lane
- Broadwas On Teme
- Worcester WR6 5PA
- England, United Kingdom
Garland Surgical Timeline
Garland Surgical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series A2) | 31-Jan-2028 | $6M | Upcoming | Product Development | ||
| 10. Later Stage VC (Series A1) | 19-May-2026 | In Progress | Product Development | |||
| 9. Seed Round | 05-Feb-2026 | Completed | Product Development | |||
| 8. Accelerator/Incubator | 07-Mar-2025 | Completed | Product Development | |||
| 7. Accelerator/Incubator | 19-Jun-2024 | Completed | Product Development | |||
| 6. Grant | 01-Jan-2024 | Completed | Product Development | |||
| 5. Accelerator/Incubator | 01-Jan-2024 | Completed | Product Development | |||
| 4. Seed Round | 12-Jun-2023 | Completed | Product Development | |||
| 3. Grant | 01-Jan-2023 | $30.7K | Completed | Startup | ||
| 2. Grant | 01-Jan-2023 | $299K | Completed | Product Development |
Garland Surgical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary B | ||||||||
| Ordinary B | ||||||||
| Ordinary B | ||||||||
| Ordinary A | ||||||||
| Ordinary B | ||||||||
| Ordinary A | 135 | $0.001354 | $2504.8 | $2504.8 | 1x | $2504.8 | 7.32% | |
| Ordinary A | 81 | $0.001354 | $1753.37 | $1753.37 | 1x | $1753.37 | 4.39% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Garland Surgical Signals
Garland Surgical Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dedaub | Corporation | Minority | ||
| Guarn | Corporation | Minority | ||
| Malta Venture Capital | Venture Capital | Minority | ||
| ScaleUps Ventures | Accelerator/Incubator | |||
| BetaDen | Accelerator/Incubator |
Garland Surgical FAQs
-
Where is Garland Surgical headquartered?
Garland Surgical is headquartered in Worcester, United Kingdom.
-
What is the size of Garland Surgical?
Garland Surgical has 8 total employees.
-
What industry is Garland Surgical in?
Garland Surgical’s primary industry is Therapeutic Devices.
-
Is Garland Surgical a private or public company?
Garland Surgical is a Private company.
-
What is Garland Surgical’s current revenue?
The current revenue for Garland Surgical is .
-
How much funding has Garland Surgical raised over time?
Garland Surgical has raised $3.85M.
-
Who are Garland Surgical’s investors?
Dedaub, Guarn, Malta Venture Capital, ScaleUps Ventures, and BetaDen are 5 of 11 investors who have invested in Garland Surgical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process